quantikine human il 10 Search Results


human il 1ra quantikine immunoassay  (R&D Systems)
90
R&D Systems human il 1ra quantikine immunoassay
Human Il 1ra Quantikine Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 1ra quantikine immunoassay/product/R&D Systems
Average 90 stars, based on 1 article reviews
human il 1ra quantikine immunoassay - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human soluble il 6r alpha quantikine elisa kit  (R&D Systems)
94
R&D Systems human soluble il 6r alpha quantikine elisa kit
Human Soluble Il 6r Alpha Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human soluble il 6r alpha quantikine elisa kit/product/R&D Systems
Average 94 stars, based on 1 article reviews
human soluble il 6r alpha quantikine elisa kit - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
mouse il 12 p70 elisa kit  (R&D Systems)
95
R&D Systems mouse il 12 p70 elisa kit
Mouse Il 12 P70 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse il 12 p70 elisa kit/product/R&D Systems
Average 95 stars, based on 1 article reviews
mouse il 12 p70 elisa kit - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
dst200 st2 quantikine kit  (R&D Systems)
95
R&D Systems dst200 st2 quantikine kit
Fig. 1. Normalized protein expression (NPX) of plasma biomarkers in surviving [sTBI (S); n 5 6] and non- surviving sTBI patients [sTBI (NS); n 5 4] compared with matched healthy controls (CTR, n 5 10). Biomarkers shown are (A) <t>ST2,</t> (B) IL6, (C) TNNI3, (D) TNFR-2, (E) CHI3L1, and (F) EN-RAGE. Reference groups shown are ovarian cancer patients (OvCa, n 5 32) and dementia patients (mild cognitive impair- ment, MCI, n 5 18; Alzheimer disease, AD, n 5 12). Dotted lines represent group median, bars show interquartile range. Mann Whitney U test; *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant. For more discussion see text.
Dst200 St2 Quantikine Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dst200 st2 quantikine kit/product/R&D Systems
Average 95 stars, based on 1 article reviews
dst200 st2 quantikine kit - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
human il 10 immunoassay hs100c  (R&D Systems)
94
R&D Systems human il 10 immunoassay hs100c
Fig. 1. Normalized protein expression (NPX) of plasma biomarkers in surviving [sTBI (S); n 5 6] and non- surviving sTBI patients [sTBI (NS); n 5 4] compared with matched healthy controls (CTR, n 5 10). Biomarkers shown are (A) <t>ST2,</t> (B) IL6, (C) TNNI3, (D) TNFR-2, (E) CHI3L1, and (F) EN-RAGE. Reference groups shown are ovarian cancer patients (OvCa, n 5 32) and dementia patients (mild cognitive impair- ment, MCI, n 5 18; Alzheimer disease, AD, n 5 12). Dotted lines represent group median, bars show interquartile range. Mann Whitney U test; *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant. For more discussion see text.
Human Il 10 Immunoassay Hs100c, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 10 immunoassay hs100c/product/R&D Systems
Average 94 stars, based on 1 article reviews
human il 10 immunoassay hs100c - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
quantikine hs human il  (R&D Systems)
93
R&D Systems quantikine hs human il
Fig. 1. Normalized protein expression (NPX) of plasma biomarkers in surviving [sTBI (S); n 5 6] and non- surviving sTBI patients [sTBI (NS); n 5 4] compared with matched healthy controls (CTR, n 5 10). Biomarkers shown are (A) <t>ST2,</t> (B) IL6, (C) TNNI3, (D) TNFR-2, (E) CHI3L1, and (F) EN-RAGE. Reference groups shown are ovarian cancer patients (OvCa, n 5 32) and dementia patients (mild cognitive impair- ment, MCI, n 5 18; Alzheimer disease, AD, n 5 12). Dotted lines represent group median, bars show interquartile range. Mann Whitney U test; *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant. For more discussion see text.
Quantikine Hs Human Il, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantikine hs human il/product/R&D Systems
Average 93 stars, based on 1 article reviews
quantikine hs human il - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
il1rn  (R&D Systems)
95
R&D Systems il1rn
Fig. 1. Normalized protein expression (NPX) of plasma biomarkers in surviving [sTBI (S); n 5 6] and non- surviving sTBI patients [sTBI (NS); n 5 4] compared with matched healthy controls (CTR, n 5 10). Biomarkers shown are (A) <t>ST2,</t> (B) IL6, (C) TNNI3, (D) TNFR-2, (E) CHI3L1, and (F) EN-RAGE. Reference groups shown are ovarian cancer patients (OvCa, n 5 32) and dementia patients (mild cognitive impair- ment, MCI, n 5 18; Alzheimer disease, AD, n 5 12). Dotted lines represent group median, bars show interquartile range. Mann Whitney U test; *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant. For more discussion see text.
Il1rn, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il1rn/product/R&D Systems
Average 95 stars, based on 1 article reviews
il1rn - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
human il 1 alpha il 1f1 quantikine elisa kit  (R&D Systems)
95
R&D Systems human il 1 alpha il 1f1 quantikine elisa kit
Fig. 1. Normalized protein expression (NPX) of plasma biomarkers in surviving [sTBI (S); n 5 6] and non- surviving sTBI patients [sTBI (NS); n 5 4] compared with matched healthy controls (CTR, n 5 10). Biomarkers shown are (A) <t>ST2,</t> (B) IL6, (C) TNNI3, (D) TNFR-2, (E) CHI3L1, and (F) EN-RAGE. Reference groups shown are ovarian cancer patients (OvCa, n 5 32) and dementia patients (mild cognitive impair- ment, MCI, n 5 18; Alzheimer disease, AD, n 5 12). Dotted lines represent group median, bars show interquartile range. Mann Whitney U test; *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant. For more discussion see text.
Human Il 1 Alpha Il 1f1 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 1 alpha il 1f1 quantikine elisa kit/product/R&D Systems
Average 95 stars, based on 1 article reviews
human il 1 alpha il 1f1 quantikine elisa kit - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
il 4 quantikine elisa kit  (R&D Systems)
96
R&D Systems il 4 quantikine elisa kit
Fig. 1. Normalized protein expression (NPX) of plasma biomarkers in surviving [sTBI (S); n 5 6] and non- surviving sTBI patients [sTBI (NS); n 5 4] compared with matched healthy controls (CTR, n 5 10). Biomarkers shown are (A) <t>ST2,</t> (B) IL6, (C) TNNI3, (D) TNFR-2, (E) CHI3L1, and (F) EN-RAGE. Reference groups shown are ovarian cancer patients (OvCa, n 5 32) and dementia patients (mild cognitive impair- ment, MCI, n 5 18; Alzheimer disease, AD, n 5 12). Dotted lines represent group median, bars show interquartile range. Mann Whitney U test; *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant. For more discussion see text.
Il 4 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 4 quantikine elisa kit/product/R&D Systems
Average 96 stars, based on 1 article reviews
il 4 quantikine elisa kit - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
il 17a  (R&D Systems)
94
R&D Systems il 17a
Plasma cytokine levels in moderate versus severe CDI patients <xref ref-type= a " width="250" height="auto" />
Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 17a/product/R&D Systems
Average 94 stars, based on 1 article reviews
il 17a - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
il 1β  (R&D Systems)
94
R&D Systems il 1β
Plasma cytokine levels in moderate versus severe CDI patients <xref ref-type= a " width="250" height="auto" />
Il 1β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 1β/product/R&D Systems
Average 94 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
quantikine human il 19 immunoassay kit  (R&D Systems)
93
R&D Systems quantikine human il 19 immunoassay kit
Plasma cytokine levels in moderate versus severe CDI patients <xref ref-type= a " width="250" height="auto" />
Quantikine Human Il 19 Immunoassay Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantikine human il 19 immunoassay kit/product/R&D Systems
Average 93 stars, based on 1 article reviews
quantikine human il 19 immunoassay kit - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. Normalized protein expression (NPX) of plasma biomarkers in surviving [sTBI (S); n 5 6] and non- surviving sTBI patients [sTBI (NS); n 5 4] compared with matched healthy controls (CTR, n 5 10). Biomarkers shown are (A) ST2, (B) IL6, (C) TNNI3, (D) TNFR-2, (E) CHI3L1, and (F) EN-RAGE. Reference groups shown are ovarian cancer patients (OvCa, n 5 32) and dementia patients (mild cognitive impair- ment, MCI, n 5 18; Alzheimer disease, AD, n 5 12). Dotted lines represent group median, bars show interquartile range. Mann Whitney U test; *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant. For more discussion see text.

Journal: The journal of applied laboratory medicine

Article Title: Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury-A Pilot Study.

doi: 10.1093/jalm/jfab004

Figure Lengend Snippet: Fig. 1. Normalized protein expression (NPX) of plasma biomarkers in surviving [sTBI (S); n 5 6] and non- surviving sTBI patients [sTBI (NS); n 5 4] compared with matched healthy controls (CTR, n 5 10). Biomarkers shown are (A) ST2, (B) IL6, (C) TNNI3, (D) TNFR-2, (E) CHI3L1, and (F) EN-RAGE. Reference groups shown are ovarian cancer patients (OvCa, n 5 32) and dementia patients (mild cognitive impair- ment, MCI, n 5 18; Alzheimer disease, AD, n 5 12). Dotted lines represent group median, bars show interquartile range. Mann Whitney U test; *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant. For more discussion see text.

Article Snippet: All sTBI and matched control samples were analyzed in duplicate using the commercially available ELISA kits, DRT200 TNFR2 Quantikine kit and the DST200 ST2 Quantikine kit (R&D Systems), according to manufacturer’s instructions.

Techniques: Expressing, Clinical Proteomics, MANN-WHITNEY

Fig. 3. Plasma concentration of ST2 and TNFR-2 in healthy controls (n 5 10) and sTBI patients (n 5 10), as measured by commercially available ELISAs. Mann Whitney U test; ****P < 0.0001. For more details see text.

Journal: The journal of applied laboratory medicine

Article Title: Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury-A Pilot Study.

doi: 10.1093/jalm/jfab004

Figure Lengend Snippet: Fig. 3. Plasma concentration of ST2 and TNFR-2 in healthy controls (n 5 10) and sTBI patients (n 5 10), as measured by commercially available ELISAs. Mann Whitney U test; ****P < 0.0001. For more details see text.

Article Snippet: All sTBI and matched control samples were analyzed in duplicate using the commercially available ELISA kits, DRT200 TNFR2 Quantikine kit and the DST200 ST2 Quantikine kit (R&D Systems), according to manufacturer’s instructions.

Techniques: Clinical Proteomics, Concentration Assay, MANN-WHITNEY

Fig. 4. Comparison between commercially available proximity extension assays (Olink Proteomics) and ELISAs. Plasma ST2 was measured in (A) healthy controls (n 5 10); Spearman’s correlation (rs) 5 0.8909, P 5 0.0011, and (B) sTBI patients (n 5 10); rs 5 0.9758, P < 0.0001. Plasma TNFR-2 was measured in (A) healthy controls (n 5 10); rs 5 0.9030, P 5 0.0008, and (B) sTBI patients (n 5 10); rs 5 0.8667, P 5 0.0022. Black line shows line of best fit.

Journal: The journal of applied laboratory medicine

Article Title: Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury-A Pilot Study.

doi: 10.1093/jalm/jfab004

Figure Lengend Snippet: Fig. 4. Comparison between commercially available proximity extension assays (Olink Proteomics) and ELISAs. Plasma ST2 was measured in (A) healthy controls (n 5 10); Spearman’s correlation (rs) 5 0.8909, P 5 0.0011, and (B) sTBI patients (n 5 10); rs 5 0.9758, P < 0.0001. Plasma TNFR-2 was measured in (A) healthy controls (n 5 10); rs 5 0.9030, P 5 0.0008, and (B) sTBI patients (n 5 10); rs 5 0.8667, P 5 0.0022. Black line shows line of best fit.

Article Snippet: All sTBI and matched control samples were analyzed in duplicate using the commercially available ELISA kits, DRT200 TNFR2 Quantikine kit and the DST200 ST2 Quantikine kit (R&D Systems), according to manufacturer’s instructions.

Techniques: Comparison, Clinical Proteomics

Plasma cytokine levels in moderate versus severe CDI patients <xref ref-type= a " width="100%" height="100%">

Journal: mBio

Article Title: Immune Profiling To Predict Outcome of Clostridioides difficile Infection

doi: 10.1128/mBio.00905-20

Figure Lengend Snippet: Plasma cytokine levels in moderate versus severe CDI patients a

Article Snippet: Some analytes, including sST-2 (catalog no. DST 200; R&D Systems), IL-23 (catalog no. D2300B; R&D Systems), and IL-17A (catalog no. HS170; R&D Systems), were measured by using an enzyme-linked immunosorbent assay (ELISA).

Techniques: Clinical Proteomics, Biomarker Discovery